Alopecia Areata Trial, Recruiting NCT05213936 Sponsor: Montefiore Medical Center Condition: Alopecia Areata
Back to Alopecia Areata

Alopecia Areata Trial, Recruiting

NCT05213936
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You are female
  • Your natural hair type is curly (type 3) or kinky/coily (type 4)
  • You have been diagnosed with breast cancer, non-small cell lung cancer, or a gynecologic cancer (any stage from I to IV)
  • You are about to start at least 4 cycles of a chemotherapy treatment that includes a type of drug called a taxane, with the goal of curing your cancer
  • Certain other chemotherapy drugs given at the same time are also allowed, including HER-targeted therapy, cisplatin, cyclophosphamide, and doxorubicin
  • You are generally able to care for yourself and carry out light daily activities, even if you cannot do heavy physical work

Who may not be able to join:

  • Your natural hair type is anything other than curly (type 3) or kinky/coily (type 4)
  • You are male
  • You currently wear hair weaves or extensions and do not plan to remove them
  • You have another cancer at the same time, including blood cancers such as leukemia or lymphoma
  • You already have significant hair loss before starting the trial (confirm with trial site)
  • You received chemotherapy within the last 10 years
  • You have a history of migraines, cluster headaches, an eating disorder called anorexia, severe anemia, uncontrolled diabetes, hepatitis, thyroid problems, cold-triggered hives, a condition called cold agglutinin disease, or cancer that has spread to the scalp
  • You are planned to have very high-dose chemotherapy that destroys bone marrow, or radiation to the skull
  • You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Beth McLellan, MD, Montefiore Medical Center

Phone: (718) 862-8840

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Montefiore Medical Center
Registry
ClinicalTrials.gov
Start date
24 October 2022
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Severity of chemotherapy-induced alopecia - hair count density; Severity of chemotherapy-induced alopecia - adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov